Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

5.57
+0.580011.62%
Post-market: 5.40-0.1670-3.00%19:30 EDT
Volume:72.11K
Turnover:391.82K
Market Cap:11.19M
PE:-0.53
High:5.88
Open:5.29
Low:5.02
Close:4.99
52wk High:41.80
52wk Low:3.25
Shares:2.01M
Float Shares:1.63M
Volume Ratio:2.98
T/O Rate:4.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.4278
EPS(LYR):-14.7963
ROE:-575.73%
ROA:-114.60%
PB:2.84
PE(LYR):-0.38

Loading ...

Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes

TIPRANKS
·
Aug 21

Quoin Pharmaceuticals Shareholders Approved 401(k) Matching Contribution Changes at Annual Meeting

Reuters
·
Aug 21

Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)

TIPRANKS
·
Aug 16

Quoin Pharmaceuticals Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Quoin Pharmaceuticals Q2 EPS $(1.90) Misses $(1.61) Estimate

Benzinga Earnings
·
Aug 14

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 14

Quoin Pharmaceuticals Ltd Expected to Post a Loss of $1.61 a Share - Earnings Preview

Reuters
·
Aug 12

Quoin Pharmaceuticals Updates Financial Calendar, Sets Q2 Results Release and Corporate Update

Reuters
·
Aug 07

Quoin Pharmaceuticals Ltd Expected to Post a Loss of $1.61 a Share - Earnings Preview

Reuters
·
Aug 03

Insider Traders Lose US$65k As Quoin Pharmaceuticals Drops

Simply Wall St.
·
Jul 16

Maxim Group Remains a Buy on Quoin Pharmaceuticals (QNRX)

TIPRANKS
·
Jul 10

Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application

TIPRANKS
·
Jul 09

Quoin Pharma Wins FDA IND Clearance for Qrx003 in Peeling Skin Syndrome

Reuters
·
Jul 09

Quoin Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Jul 07

Quoin Pharmaceuticals receives notice of allowance for QRX003 patent

TIPRANKS
·
Jun 30

Quoin Pharma Wins US Notice of Allowance for Netherton Syndrome Combination-treatment Patent Application

Reuters
·
Jun 30

NASDAQ Trade Halt Volatility Trading Pause at 09:57 Am

Reuters
·
Jun 24

Quoin Pharmaceuticals Ltd : Maxim Group Cuts Target Price to $16 From $40

THOMSON REUTERS
·
Jun 23

Quoin Pharmaceuticals' Potential Skin Disease Treatment Receives US Name Approval

MT Newswires Live
·
Jun 23

Quoin says FDA conditionally approves QYLEKI as brand name for QRX003 Netherton syndrome drug

Reuters
·
Jun 23